As shown in Figure 6, indoximod influenced the pathological process of nonalcoholic fatty liver disease through regulated TNFa, AP-1, AKT, PI3K, etc. The results indicated that indoximod may be an effective drug for nonalcoholic fatty liver. The gene discussed is AKT1; the disease is non-alcoholic fatty liver.